-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2016 to Q1 2025.
- Heron Therapeutics, Inc. /De/ Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2025 was $636K, a 2% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $4.86M, a 58.9% increase from 2023.
- Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.06M, a 36% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.25M, a 80.9% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)